Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) series of randomized, controlled trials has assessed the role of atorvastatin loading prior to percutaneous coronary intervention (PCI) in both stable and unstable coronary syndromes.

Atorvastatin Reload Prior to PCI for Patients on Chronic Statin Therapy